Benzinga | Jul 16, 2021 07:01AM EDT

GlaxoSmithKline Reports Results For Daprodustat Phase 3 Headline Trial: Study Met Primary Efficacy Endpoint, Co. Will Continue Data Analysis In Phase 3 ASCEND Trial

-Reuters